Valuation dashboard for Option Care Health, Inc. (OPCH) with P/E 23.83, P/B 3.89, EV/EBITDA 14.1 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses.
What would it be worth at its usual multiples?
Versus its usual multiples: cheap · Current P/E 23.8× · Multiples range: $40.82 · $40.82.
At its sector median (30.7×) $41 (+29 %). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
Analysis Summary
Option Care Health, Inc. reported revenue of $5.65B in the most recent fiscal year, growing at a 5-year CAGR of 13.3%.
Trailing-twelve-month margins: gross margin 18.2%, operating margin 5.9%, net margin 3.7%.
At $31.69 (closing price, November 2, 2026), OPCH trades at a P/E of 23.83 and an ROE of 15.83%. Market capitalisation stands at $4.7B.
Balance sheet quality for OPCH: debt-to-equity ratio of 1.01, current ratio of 1.47 over the last 12 months. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 23.83 |
| Price / Book | 3.89 |
| EV / EBITDA | 14.1 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| OPCH | Option Care Health, Inc. | $4.7B | 23.83 | 3.89 | 15.8% |
| ENSG | The Ensign Group, Inc. | $10.4B | 26.65 | 4.05 | 16.6% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.9B | 10.39 | 9.95 | 150.2% |
| EHC | Encompass Health Corporation | $13.5B | 21.44 | 5.03 | 25.2% |
| CHE | Chemed Corporation | $7.1B | 25.93 | 8.22 | 32.1% |
Price
| Price | $31.69 (closing price, November 2, 2026) |
| Market Cap | $4.7B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 15.83% |
| Return on Invested Capital | 9.59% |
| Return on Assets | 6.20% |
| Gross Margin | 18.17% |
| Operating Margin | 5.94% |
| Net Margin | 3.68% |
Related companies: ENSG · AVAH · EHC · CHE
Explore sector: Healthcare · Medical - Care Facilities
More sections of OPCH: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks